University of Tokyo and Keio University joined multiple corporates in a round that brought the pre-clinical drug developer's funding haul to $33.1m.

The Harvard motor neurone disease drug developer secured the return of Amgen Ventures for its series A round.

The e-bike producer raised $13.5m from investors including its production ally Sinbon Electronics to bring its overall funding haul to $21m.

A host of corporate investors including BIVF, Axa Venture Partners and New York Life Ventures invested to bring prescription adherence app developer Wellth's total to $17.1m.

Smart electricity panel developer Span has secured $10.2m in funding six months after it received financing from Wells Fargo Strategic Capital.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Baidu Ventures portfolio company Qitan Technology has pulled in $14.1m to progress its pathogen detection technology for drug development and diagnostics.

Waymo has boosted its Alphabet, Magna International and AutoNation-backed funding round to $3bn following a $750m extension provided by new investors including Fidelity.

Dexcel Pharma formed part of a consortium that has supplied $80.5m in series A financing to Kriya Therapeutics, a gene therapy developer exploiting Stanford University research.

Dexcel Pharma formed part of a consortium that has supplied $80.5m in series A financing to Kriya Therapeutics, a gene therapy developer exploiting Stanford University research.